Heart failure telemonitoring program evaluation
Part of Heart & circulation clinical trials.
This trial looks at how well a telemonitoring program works for people with heart failure. It checks if the eligibility rules used by the French health authority make sense.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be an adult aged 18 or older
- Able to read and understand French
- Must be part of the CARDIAUVERGNE telemonitoring program between January 2023 and December 2024
- Either had heart failure in the past year or have shortness of breath (NYHA class 2 or higher) with high NT-proBNP (at least 1000 pg/mL)
- Must have been removed from telemonitoring by a doctor's decision (not because of choice, death, move, or not following the program)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program where nurses teach you about heart failure and how to manage it at home before you leave the hospital. The goal is to help you feel more confident and stay healthier after you go home.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This trial tests a new way of caring for heart failure that combines in-person clinic visits with at-home monitoring using digital tools. If you join, you may be able to have more of your check-ups from home, which could be more convenient and help your care team catch problems early.
This study tests a virtual ward program for people recently hospitalized with heart failure. It aims to see if monitoring and support at home can improve recovery and quality of life.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
This study tests a new way to help diagnose heart failure in rural areas using remote blood tests (telebiology) and video appointments (telemedicine). It combines these tools to make it easier for older adults in rural areas to get diagnosed and treated sooner.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.